RB
WST icon

Renasant Bank’s West Pharmaceutical WST Stock Holding History

Renasant Bank’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-558
Closed -$229K – 205
2022
Q1 		$229K Buy
558
+21
+4% +$8.22K 0.15% 180
2021
Q4 		$252K Sell
537
-105
-16% -$45.2K 0.17% 171
2021
Q3 		$272K Sell
642
-1
-0.2% -$422 0.22% 143
2021
Q2 		$231K Buy
+643
New +$212K 0.17% 159

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Renasant Bank's WST Position: Q2 2022 in Review

Renasant Bank sold out of West Pharmaceutical (WST) in Q2 2022, closing a stake of 558 shares — an estimated $229K sold.

Renasant Bank first reported a position in WST in Q2 2021 and held it in 4 quarters. The position peaked at $272K in Q3 2021. 655 funds tracked by Wall St. Rank hold WST as of Q2 2022.

  • Renasant Bank reported no remaining West Pharmaceutical position as of Q2 2022 after selling out during the quarter.
  • Renasant Bank sold 558 West Pharmaceutical shares in Q2 2022, an estimated $229K.
  • Renasant Bank first reported a position in West Pharmaceutical in Q2 2021 and held it in 4 quarters.
  • Renasant Bank's West Pharmaceutical position peaked at $272K in Q3 2021.
  • 655 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2022.

Based on Renasant Bank's 13F filing for Q2 2022, filed 3 Aug 2022.